← Every insider
Dino A Rossi
Director. Files against KRYS. Everything below is filed with the SEC within two business days of the trade. Filed as ROSSI DINO A.
Filed lines
11
2026-08-14 to 2026-09-14
Bought
—
open market
Sold
$8.2M
open market
Net
$8.2M
sold more
Every reported line
Purchases, sales, grants, option exercises and shares withheld for tax.
| Company | Action | Value |
|---|---|---|
| KRYSKrystal Biotech Inc2026-09-14 | Grantderivative | — |
| KRYSKrystal Biotech Inc2026-09-14 | Grantderivative | — |
| KRYSKrystal Biotech Inc2026-08-14 | Gift | — |
| KRYSKrystal Biotech Inc2026-08-14 | Sale | $111K |
| KRYSKrystal Biotech Inc2026-08-14 | Sale | $746.9K |
| KRYSKrystal Biotech Inc2026-08-14 | Sale | $1.7M |
| KRYSKrystal Biotech Inc2026-08-14 | Sale | $554.2K |
| KRYSKrystal Biotech Inc2026-08-14 | Sale | $2.4M |
| KRYSKrystal Biotech Inc2026-08-14 | Sale | $1.6M |
| KRYSKrystal Biotech Inc2026-08-14 | Sale | $1M |
| KRYSKrystal Biotech Inc2026-08-14 | Sale | $13.3K |
Source: SEC Form 4 and Form 144 filings, via EDGAR. Form 144 carries no filer identifier, so those notices are matched to this page by name alone. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.
Follow Dino A Rossi by email
Dino A Rossi's new Form 4 trades, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.